Morice, A H, Birring, S S, Smith, J A, McGarvey, L P, Schelfhout, J, Martin Nguyen, A, Xu, Z J, Wu, W C, Muccino, D R & Sher, M R 2021, ' Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant ', Lung, vol. 199, no. 2, pp. 121-129 . https://doi.org/10.1007/s00408-021-00437-7 Morice, A H, Birring, S S, Smith, J A, McGarvey, L P, Schelfhout, J, Martin Nguyen, A, Xu, Z J, Wu, W-C, Muccino, D R & Sher, M R 2021, ' Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant ', Lung, vol. 199, no. 2, pp. 121-129 . https://doi.org/10.1007/s00408-021-00437-7 Lung
Smith, J, Kitt, M M, Butera, P, Smith, S A, Li, Y, Xu, Z J, Holt, K, Sen, S, Sher, M R & Ford, A P 2020, ' Gefapixant in two randomised dose-escalation studies in chronic cough ', European Respiratory Journal . https://doi.org/10.1183/13993003.01615-2019